| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/24/2000 | WO1999066949A3 An antimicrobial effective against gram-positive pathogens |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999062459A3 Agents and methods for protection, treatment and repair of connective tissue |
| 02/24/2000 | WO1999060011A9 Secretion of toxins by gram-negative bacteria |
| 02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
| 02/24/2000 | WO1999058685A3 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 02/24/2000 | WO1999058098A8 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 02/24/2000 | WO1999057133A3 Inhibitors of nf-kb activation |
| 02/24/2000 | WO1999045950A9 Methods of suppressing microglial activation |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | DE19837540A1 Composition for curing age-related diseases associated with thyroid dysfunction, containing thyroid hormone or thyreotrophin stimulating hormone |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | DE19834610A1 New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders |
| 02/24/2000 | DE19828624C1 Modular aufgebaute RNA-Moleküle mit zwei Sequenzbereichstypen Modular RNA molecules with two types of sequence region |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2340392A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 02/24/2000 | CA2340258A1 Methods for treatment of neurological disorders |
| 02/24/2000 | CA2340257A1 Treatment of disease states |
| 02/24/2000 | CA2340223A1 Nutritional compositions for preventing or treating hyperlipoproteinemia |
| 02/24/2000 | CA2340106A1 Purification of blood clotting proteins |
| 02/24/2000 | CA2340091A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339833A1 Blood sugar level controlling agent |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339575A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339330A1 Methods to increase blood flow to ischemic tissue |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2339303A1 Methods of forming neurons |
| 02/24/2000 | CA2339302A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338885A1 Antimicrobial peptides isolated from the skin of american frogs |
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2333901A1 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
| 02/24/2000 | CA2305768A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | CA2301201A1 Method of inhibiting cathepsin k |
| 02/23/2000 | EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges |
| 02/23/2000 | EP0980526A1 Inhibitors of nuclear protein/nuclear receptor interaction |
| 02/23/2000 | EP0980432A1 Chimeric opg polypeptides |
| 02/23/2000 | EP0980430A1 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis |
| 02/23/2000 | EP0980428A2 TECHNIQUES AND COMPOSITIONS FOR TREATING HEART FAILURE AND VENTRICULAR REMODELING BY $i(IN VIVO) DELIVERY OF ANGIOGENIC TRANSGENES |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980424A2 Enzymatic nucleic acids: synthesis, selection and use |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | EP0980388A1 Vif-derived hiv protease inhibitors |
| 02/23/2000 | EP0980387A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 02/23/2000 | EP0980386A2 Estrogen receptor crystals and ligands |
| 02/23/2000 | EP0980385A1 Peptides and compounds that bind to the il-5 receptor |
| 02/23/2000 | EP0980380A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/23/2000 | EP0980373A1 Reverse-turn mimetics and methods relating thereto |
| 02/23/2000 | EP0980273A1 Biodegradable osteosynthesis implant |
| 02/23/2000 | EP0980263A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 02/23/2000 | EP0980261A1 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals |
| 02/23/2000 | EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/23/2000 | EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
| 02/23/2000 | EP0980254A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| 02/23/2000 | EP0980253A1 Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x |
| 02/23/2000 | EP0980252A1 Therapies for acute renal failure |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
| 02/23/2000 | EP0980205A1 Method of treating malignancies |
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | EP0980203A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 02/23/2000 | CN1245536A Novel calpaines, production and use thereof |
| 02/23/2000 | CN1245533A Mammalian chemokines |
| 02/23/2000 | CN1245504A Peptides and compounds that bind to receptor |
| 02/23/2000 | CN1245436A Pharmaceutical formulations for sustained drug delivery |
| 02/23/2000 | CN1245434A Stable liquid interferon formulations |
| 02/23/2000 | CN1245074A Medicine for reducing acidity in vegina and its usage |
| 02/23/2000 | CN1049602C Compound injection for curing ischemic ophthalmopathy |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028196 Using inexpensive and environmentally acceptable starting materials reagents and solvents, no chromatographic purification of intermediate spiroindoline sulfonamide to produce the stimulants for releasing somatotropin |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6028176 High-affinity interleukin-4 muteins |
| 02/22/2000 | US6028174 Method of diagnosing and treating gliomas |
| 02/22/2000 | US6028171 Class I MHC modulation of surface receptor activity |
| 02/22/2000 | US6028170 Analogs of hirudin |
| 02/22/2000 | US6028169 Chemokine β-6 antagonists |
| 02/22/2000 | US6028164 Bioresorbable compositions for implantable prostheses |
| 02/22/2000 | US6028087 Platelet aggregation inhibiting compounds |
| 02/22/2000 | US6028067 As immunosuppressant |
| 02/22/2000 | US6028058 Methods and compositions for regulating nuclear trafficking of proteins |
| 02/22/2000 | US6028057 Inducing pseudopregnancy in fertile female pigs comprising administering to the pigs an effective amount of a compound that induces pseudopregnancy in a biodegradable controlled release formulation |
| 02/22/2000 | US6028056 Useful for in vivo detection and diagnosis of thrombi. the precursor reagents of the invention may also be used in production of antithrombotic agents derived from apcitide |